Familial Hypokalemic Periodic Paralysis
📧 Sign up to get email alerts when something new happens for Familial Hypokalemic Periodic Paralysis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-19FDA Approved: KEVEYIS — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approved a supplemental application for Keveyis (dichlorphenamide) from Xeris Pharmaceuticals, indicating a labeling/indication update.
-
FDA approval · 2012-03-16FDA Approved: KEVEYIS — Supplemental Application (Xeris Pharmaceuticals, Inc.)
The FDA approved a supplemental application for KEVEYIS (dichlorphenamide) submitted by Xeris Pharmaceuticals, expanding the drug's labeling…